Update on ingestibles product range

RNS Number : 1909I

Cellular Goods PLC

13 April 2022

 

The information contained within this announcement is deemed by the Company to constitute inside

information stipulated under the Market Abuse Regulation (EU) No. 596/2014, as retained as part of

the law of England and Wales. Upon the publication of this announcement via the Regulatory

Information Service, this inside information is now considered to be in the public domain.

Press release

13 April 2022

Cellular Goods PLC

('Cellular Goods' or 'the Company')

Update on ingestibles product range

Further to the announcement of 11 April 2022, the Company provides an update concerning its communications with the Food Standards Authority ("FSA") with regards to its ingestibles range.

The FSA's current position is that any new products not on sale before February 2020 are not eligible for the public list and therefore should not be available for sale. As announced previously, the Company's branded products are manufactured and supplied by Chanelle McCoy Health ("CMH"), whose products are validated and included on the FSA's permitted list published on 31 March 2022.

Cellular Goods is currently considering its position pending advice from the company's advisers and is also seeking further clarification on the FSA's stance, considering that these products are identical to the validated products from CMH. The Company's skincare range, which accounts for the bulk of its overall sales, remains unaffected.

For further information please contact:

Cellular Goods
Anna Chokina Chief Executive Neil Thapar Investor Relations	via Tancredi [phone] [phone]
Tennyson Securities
Corporate Broker Peter Krens	[phone]
Novum Securities
Corporate Broker Colin Rowbury Jon Belliss	[phone]
Tancredi Intelligent Communication
Media Relations Helen Humphrey Gabriela Amaya Garcia Charlie Hobbs [e-mail]	[phone] [phone] [phone]

About Cellular Goods PLC:

Cellular Goods is a UK-based wellness company that provides premium products based on lab-made cannabinoids. It was established in August 2018 to develop efficacy-led and research-backed cannabinoid-powered wellness products. The initial focus is on three product verticals: Function Better, Feel Better and Look Better. These three verticals encompass Cellular Goods' premium CBG skincare and CBD ingestible and topical athletic recovery products, with the first products launched in December 2021 initially through the Company's website. The Company's shares are listed on the main market of the London Stock Exchange. www.cellular-goods.com  

 

END

 

 

UPDSFSESEEESELL